熱門資訊> 正文
Praxis精密药品宣布拟议公开募股
2025-10-17 04:05
- Praxis Precision Medicines (NASDAQ:PRAX) said on Thursday it plans to offer shares of its common stock and prefunded warrants in a public offering, with all securities to be sold by the company.
- The size and pricing of the offering were not disclosed.
- The company granted underwriters a 30-day option to buy up to 15% additional shares.
- PRAX -2.92% after hours to $157.78.
- Source: Press Release
More on Praxis Precision Medicines
- Praxis: Positive 8-Week Radiant Study Data Leads To Other Expected Catalysts
- Praxis surges after late-stage trial success for movement disorder therapy
- Biggest stock movers Thursday: PRAX, HPE, GRAL, FOSL, VERI, and more
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
